Honestly Finesand , I can never follow your numbers , I

New Post Public Reply Private Reply Replies (1) Message Board
misiu143 finesand #740
173
Honestly Finesand , I can never follow your numbers , I cant ever understand them...I am not sure if you do...

Right now we see about 86 % efficacy or so in mono , and so far not one after 12 weeks failed in 700 up to 24 weeks ...

and we know that after 10 weeks with longer overlap with HAART it was
100 % efficacy with 22 patients with 700 mg and 90% with 525 in 101patients.

I will be going and follow those numbers ...

And I never saw results like that in medicine without one single , serious side effect...

And those are important thing to me , you and Amatuer can look for negative here...
I dont see them...









CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Gaby Natale to Inspire at Procter & Gamble's LatinOvation

Updated Category News Views 189

Gaby Natale to Motivate at Procter & Gamble's LatinOvation Gaby Natale, a celebrated triple Emmy award-winning journalist and bestselling author, is poised to deliver the impactful closing keynote at Procter & Gamble's annual LatinOvation event. This year, the gathering continues to honor the substantial contributions from the Hispanic community, rallying around the theme...

Continue Reading
GitLab's Market Resilience and Adjustments in Earnings Outlook

Updated Category News Views 124

GitLab's Steady Growth Amid Price Forecast Adjustments In recent developments, analyst Pinjalim Bora from JP Morgan has reiterated a Neutral rating on GitLab Inc. (NASDAQ: GTLB), adjusting the price forecast from $65 down to $62. Quarterly Performance Shines GitLab’s recent quarterly earnings report revealed surprising strength, with the company posting earnings of 33...

Continue Reading
Understanding Recent Trading Trends for Exxon Mobil Options

Updated Category News Views 73

Insights into Exxon Mobil Options Trading Recent analysis highlights a bullish trend in Exxon Mobil's trading activity. Our examination of the stock, identified by the symbol XOM, has uncovered significant patterns in the options market. Our investigation into the history of options trading shows that 53% of traders are leaning towards a bullish outlook, while 33% have a...

Continue Reading
Ming Tsai Launches Exciting New Frozen Meals Across Stores

Updated Category News Views 519

Ming Tsai Launches Exciting New Frozen Meals Nationwide Ming Tsai, an acclaimed chef known for his innovative culinary skills, has recently introduced a new line of products called Mings™ frozen meals. This line aims to transport your taste buds across Asia with authentic flavors that can now be found in Walmart stores across the country. A Culinary Adventure Awaits...

Continue Reading
Truist Financial Corporation Insights on Q3 2024 Performance

Updated Category News Views 237

Truist Financial Corporation Reports Strong Q3 2024 Results Truist Financial Corporation (NYSE: TFC) released its results for the third quarter of 2024 today, showcasing its fiscal health and commitment to enhancing customer experience. The company continues to focus on delivering robust financial performance while engaging its client base and broader community. Key...

Continue Reading